Inhibition of the mechanistic target of rapamycin (mTOR) attenuates disease in the Ndufs4(KO) mouse model of LS (4, 5), and mTOR inhibitors appears to benefit some patients (6, 7). This evidence concerns the gene MTOR and Leigh syndrome.